Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products

This information collection was established to help prevent and reduce current and future disruptions in the supply of lifesaving medicines, as well as to ensure that both FDA and the public receive adequate advance notice of shortages whenever possible. Early notifications of potential shortages enables us to work with manufacturers and other stakeholders to help prevent such shortages.

The latest form for Permanent Discontinuation or Interruption in Manufacturing of Certain Drug and Biological Products expires 2021-08-31 and can be found here.